Is AUPH or AVTX more undervalued in 2026?

CirclFi compares Aurinia Pharmaceuticals Inc (AUPH) and Avalo Therapeutics, Inc. (AVTX) using 13 institutional-grade valuation models. AUPH has a Quality of Company score of 9.9/10 while AVTX scores 4.7/10.

Which is a better buy — AUPH or AVTX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do AUPH and AVTX valuations compare?

AUPH at $15.35 and AVTX at $16.13 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

AUPH vs AVTX Valuation Comparison 2026 — Intrinsic Value Analysis

AUPH

Biotechnology

Aurinia Pharmaceuticals Inc

Quality

9.9

out of 10

Value Trap

SAFE

Price

$15.35

Last close

Models

13/13

Active

AVTX

Biotechnology

Avalo Therapeutics, Inc.

Quality

4.7

out of 10

Value Trap

WARN

Price

$16.13

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	AUPH Fair Value	AUPH Upside	AVTX Fair Value	AVTX Upside
Bayesian DCF	Intrinsic	$15.99	+4.1%	$4.59	-71.6%
Earnings Power Value	Intrinsic	$6.74	-56.1%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$17.24	+12.3%	$0.69	-95.7%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for AUPH vs AVTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AUPH vs AVTX — Which Stock Is More Undervalued?

AUPH scores higher with a 9.9/10 quality rating vs AVTX's 4.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Aurinia Pharmaceuticals Inc (AUPH) and Avalo Therapeutics, Inc. (AVTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AUPH currently trades at $15.35 with a QOC of 9.9/10, while AVTX trades at $16.13 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).